I just received an email from Partners In Health (PIH) a great healthcare organization, to which I contribute, focusing on the most needy areas of the world.
It said:
++++++++++++++++++++++++++++
Needed: Oxygen
There isn’t enough medical oxygen in the world right now, but with your help, we can close the oxygen gap.
Medical oxygen is an essential component of treatment for the 19% of COVID-19 patients who develop severe or critical disease. It literally saves lives. But even before COVID-19, many of the communities we support around the world didn’t have enough oxygen to treat everyday illnesses that restrict breathing. As the COVID-19 pandemic exploded, so did demand for this already scarce, essential medical tool.
As emergency operations began, PIH teams knew that simply sending oxygen wouldn’t be a real solution. So we worked with local ministries of health to send something far better: the ability to make medical oxygen locally.
Initially, the rapid onset of this pandemic meant sending hundreds of backpack-sized oxygen concentrators, which isolate the lifesaving gas to help individual patients breathe and survive.
But there’s more. ??Now, we’re also sending entire oxygen plants. This vital infrastructure fits into standard shipping containers and can fill hundreds of portable cylinders per week to address the chronic underlying injustice of the oxygen gap, for communities and entire countries.
++++++++++++++++++++++++++++
I responded with an email pointing out that we now also have an additional very important and less expensive approach to the oxygen problem with Zyesami (RLF100, Aviptadil) which can be extremely helpful. I included links to the Javitt recent interview and the recent study results. I addressed it to Paul Farmer the founder and to development @ PIH. I hope it gets through to Farmer who is a brilliant guy and could easily respond by seriously checking this out right way.
I urge anyone else involved with PIH, or anyone interested, to voice your understanding of Zyesami and the role it could play to help with this serious problem they are trying to overcome.
Emails are:
paul_farmer@hms.harvard.edu, development@pih.org, info@pih.org,
